Stada Arzneimittel AG Clinical Trials
Determine Stada Arzneimittel AG go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Stada Arzneimittel AG Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTXXXX | Lorem | Lorem | Lorem | XXXX | Planned | Pfizer Inc |
| An Open-label, Balanced, Randomized, Single-dose, Two-treatment, Two-sequence, Two-period, Crossover, Oral Bioequivalence Study of Fingolimod 5 mg Capsules Haupt Pharma Amareg GmbH and Gilenya 5 mg Capsules Novartis Pharma GmbH in Healthy, Adult, Human Subjects under Fasting Conditions | GDCT0434501 | fingolimod | Central Nervous System | Progressive Relapsing Multiple Sclerosis (PRMS); Relapsing Multiple Sclerosis (RMS); Relapsing Remitting Multiple Sclerosis (RRMS); Secondary Progressive Multiple Sclerosis (SPMS) | Phase I | Completed | Stada Arzneimittel AG |
| Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease (ELEGANCE) | GDCT0433492 | Lecigon | Central Nervous System | Parkinson's Disease | Phase IV | Ongoing, recruiting | Britannia Pharmaceuticals Ltd |
| Open, Randomized, Cross-over, Two-stage, Single-center Comparative Study of the Bioequivalence of Apixaban, Film-coated Tablets, 5 Mg (STADA Artsneimittel AG, Germany) and Eliquis, Film-coated Tablets, 5 Mg (Pfizer Inc. , USA) in Healthy Male Volunteers after a Single Dose on an Empty Stomach | GDCT0420997 | apixaban | Cardiovascular; Hematological Disorders | Deep Vein Thrombosis (DVT); Hemorrhage; Ischemic Stroke; Pulmonary Embolism; Stroke; Thromboembolism; Venous (Vein) Thrombosis; Venous Thromboembolism | Phase I | Completed | Stada Arzneimittel AG |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer